Exchange Announces Preliminary Designation of Jeonjin Bio Pharm as a Non-Compliant Disclosure Corporation Due to Disclosure Failures...
The Korea Exchange KOSDAQ Market Division announced on the 11th that it has given advance notice of designation as an unfaithful disclosure corporation to Jeonjin Bio Pharm due to failure to disclose and reversal of disclosure.
The deadline for the decision is the 5th of next month.
Hot Picks Today
"200,000 Won Per Person Before Chuseok"… Local Excitement Over Livelihood Support Grant in This Region
- "Betting with Advance Knowledge of Presidential Speeches"… Trump's Closest Aide Earns 150 Million Won
- Won Both 1st and 2nd Prizes With Birthday Lottery Ticket: "I Will Repay My Father Who Raised Us Alone"
- "Oops, No Condom... 'I Probably Won't Get Pregnant' – Alarming Neglect of Contraception Among Korean Adolescents"
- "Changed Gender to 'Female' Before Imprisonment, but Neo-Nazi Ultimately Sent to Male Prison"
The details include 5 cases of disclosure reversal and 1 case of failure to disclose.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
![Will the Fed Hold Off on Raising Rates in the Second Half? [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/307/2026071504434646114_1784058227.jpg)
